MB
About
Momentum Bioscience Ltd has a novel and innovative approach for the detection of infection in blood and other normally sterile body fluids. There Enzyme Mediated Amplification technology allows universal detection of viable bacteria and fungi in <2 hours vs 1-5 days with current laboratory techniques. It is the only rapid technology available that specifically measures viable organisms Momentum Bioscience Ltd is developing a suite of related technologies collectively termed Enzyme Mediated Amplification (EMA), for the rapid detection of pathogens found in blood and normally sterile fluids (NSF).
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 43 investors are based in Reading, Reading, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Reading, UK
Contact Information
linkedin.com/in/••••••••
Find more investors like Momentum
Search Investors